Showing 1761-1770 of 3812 results for "".
Weighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20985/Back to the Future
https://practicaldermatology.com/topics/practice-management/back-to-the-future/23073/Dermatology and dermatologists will look a lot different in 20 years. Here’s a sneak peek.Protect Your Data. Protect Yourself
https://practicaldermatology.com/topics/practice-management/protect-your-data-protect-yourself/22906/Fillers: Tips and Tools for Beginning and Honing Your Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/fillers-tips-and-tools-for-beginning-and-honing-your-practice/21625/Starting out small and adding new techniques one at a time is critical in the use of fillers in practice.Ethics and Dermatology: Finding Harmony in Daily Practice
https://practicaldermatology.com/topics/general-topics/PD0109_06-php/22893/While there are no easy resolutions to ethical dilemmas, experts emphasize the importance of reflection and discussion in building higher ethical standards.Lip Lifts: A Procedure to Consider
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/lip-lifts-a-procedure-to-consider/23033/Consider referring for a surgical lip lift when fillers don’t suffice.Dupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-21/23421/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-10/23206/